Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Orofacial Granulomatosis

Description

The presentation on Orofacial Granulomatosis (OFG) outlines the disorder as a term for recurrent or persistent inflammation in the orofacial region, discussing its nomenclature, clinical presentation, diagnostic evaluation, and treatment strategies. The speaker clarifies that OFG encompasses various conditions including granulomatous cheilitis and the Melkerson-Rosenthal syndrome, often linked to systemic diseases like Crohn's disease and sarcoidosis. Common symptoms include painless lip edema that can become chronic and intraoral manifestations, potentially affecting a patient’s quality of life despite functional capacity. Diagnostic evaluations focus on ruling out conditions such as inflammatory bowel disease (IBD), utilizing lab tests and imaging as needed. Although treatments are varied and many patients remain refractory, options like intralesional steroids are noted for providing symptom relief. The discussion also highlights the potential association with food allergies, emphasizing how elimination diets can yield mixed results in patients. Ultimately, the treatment approach may escalate from dietary changes to systemic therapies, including biologics, based on patient response. The presentation underscores the challenges in managing OFG, particularly its tendency to recur and the risks of disfigurement, suggesting ongoing evaluation and, in some cases, surgical options for residual symptoms.

View more

Conclusions

  • Orofacial granulomatosis is a term that encompasses both primary and secondary causes of recurrent granulomatous inflammation in the orofacial region.
  • The diagnosis of orofacial granulomatosis necessitates an evaluation for underlying inflammatory bowel disease and sarcoidosis.
  • There is a lack of standardized treatment guidelines for orofacial granulomatosis, leading to varied treatment approaches.
  • Patients with orofacial granulomatosis are at risk for chronic disfigurement, making effective treatment crucial.
  • Long-term outcomes for orofacial granulomatosis patients are uncertain, and future studies are needed to optimize diagnosis and treatment.
  • Clin Dermatol. 2016 Jul-Aug;34(4):505-13.
  • An Bras Dermatol. 2018 Jan-Feb;93(1):80-85.
  • Allergy. 2021 Jul;76(7):2189-2200.
  • Inflamm Bowel Dis. 2011 Oct;17(10):2109-15.
  • J Oral Maxillofac Pathol. 2014;18(1): S139-42.
  • Clin Gastroenterol Hepatol. 2005;3(9):886-91.
  • J Am Acad Dermatol. 2004 Aug;51(2):265-8.
  • Br J Dermatol. 2014 Apr;170(4):794-801.
  • JAMA Dermatol. 2021;157(1):112-114.